22

Kodi-M Co Ltd

224060 · KQ · Technology / Semiconductor Equipment & Materials

2,255.00KRW+100.00 (+4.64%)

Price History

Full chart

Market Stats

Previous Close2,155.00
Open2,135.00
Day Range2,135.00 – 2,350.00
52-Week Range2,400.00 – 12,750.00
Volume35.58K
Market Cap23.32B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta-0.19
50-Day Avg4,460.30
200-Day Avg4,516.93

About

THE CODI Co.,LTD. manufactures and sells semiconductor and display equipment, exposure equipment, and bio-healthcare products. It develops therapeutic agents for various diseases, such as Zika/MERS, glaucoma, non-alcoholic fatty liver, and chronic kidney diseases, as well as immunotherapy to treat cancer and inflammatory diseases. THE CODI Co.,LTD. was formerly known as CODI-M Co., LTD. and changed its name to THE CODI Co.,LTD. in November 2022. THE CODI Co.,LTD. was incorporated in 1999 and is based in Cheonan-si, South Korea.

Company Details

  • SectorTechnology
  • IndustrySemiconductor Equipment & Materials
  • CEOJungHoon Hwang
  • Employees38
  • Headquarters62, Baekseokgongdan 2-gil, Cheonan-si, South Korea, 31094, Korea
  • Websitehttps://codi-m.com

Leadership

  • JungHoon HwangCEO & Inside Director

Financials

Income Statement

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue46.65B44.26B73.50B36.58B11.79B28.04B45.36B20.11B20.21B33.52B25.27B
Growth (%)--5.13%+66.07%-50.23%-67.78%+137.91%+61.78%-55.66%+0.50%+65.82%-24.61%
Cost of Revenue42.32B42.83B65.18B37.52B9.91B27.50B45.35B20.24B21.89B28.25B20.43B
Gross Profit4.33B1.43B8.32B-936.52M1.88B543.18M8.18M-127.32M-1.67B5.27B4.83B
Gross Margin9.28%3.24%11.31%-2.56%15.93%1.94%0.02%-0.63%-8.28%15.71%19.13%
Operating Expense2.25B6.50B8.14B6.46B-2.78B10.50B-1.94B11.21B9.26B9.01B5.01B
Operating Income2.08B-5.06B178.95M-7.39B4.65B-9.96B1.95B-11.34B-10.93B-3.75B-173.32M
Operating Margin4.46%-11.44%0.24%-20.21%39.48%-35.50%4.30%-56.39%-54.08%-11.17%-0.69%
EBITDA--------19.18B-10.83B2.26B-2.37B
EBITDA Margin--------95.37%-53.56%6.75%-9.40%
Net Income1.47B-5.41B-3.30B-12.11B6.06B-12.89B-27.11B-14.10B-7.98B-3.48B24.29B
Net Income Margin3.15%-12.23%-4.49%-33.10%51.41%-45.96%-59.77%-70.13%-39.46%-10.39%96.13%
R&D111.50M119.46M64.58M165.29M150.00M144.06M117.37M684.54M27.61M399.99M-
R&D as % of Total Revenue0.24%0.27%0.09%0.45%1.27%0.51%0.26%3.40%0.14%1.19%-
Interest Expense000003.74B2.02B2.21B2.93B3.78B3.99B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%13.34%4.46%11.00%14.48%11.29%15.78%

Balance Sheet

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets20.08B68.18B60.95B93.91B117.03B125.03B122.49B93.64B99.39B94.05B72.31B
Total Liabilities7.80B52.34B5.68B37.62B51.52B45.10B66.80B46.67B67.22B48.86B61.56B
Total Equity12.28B15.85B55.27B56.29B65.51B79.93B55.69B46.97B46.93B45.19B118.69B
Cash3.80B11.28B13.71B18.92B7.18B7.20B45.25M19.80M11.54B881.00K6.18B
Total Debt---38.89M6.15B32.24B-----
Net Debt-----26.75B34.50B29.35B40.10B45.26B44.67B

Cash Flow

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow2.21B-7.91B-715.52M1.38B-20.31B-22.59B-10.80B-17.02B-6.63B-5.32B-3.68B
Investing Cash Flow-979.79M-27.45B-454.99M-36.49B-9.74B4.14B2.60B14.46B-7.57B-2.86B-
Financing Cash Flow2.56B42.84B3.66B39.97B18.50B18.23B6.15B11.86B11.29B4.76B-
Capital Expenditure1.02B1.76B1.52B4.63B288.75M1.73B288.44M87.90M5.28B486.86M1.59B
Free Cash Flow------24.49B-11.09B-17.11B-11.91B-5.80B-5.27B
FCF to OCF-----108.42%102.67%100.52%179.59%109.16%143.23%

Earnings

Report DateDec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Feb 14, 2024Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------------------
EPS Actual-465.44-1963.42-1067.60-2076.23-4172.44-4947.31-2107.99-1086.132297.42-1350.28-1464.83-1136.04-4613.04-1114.611485.36-732.234510.75-4696.30-10429.674936.70204.56-3710.06-355.04-1682.39-4336.641611.54-1074.21994.90-5789.34-155.91-507.85-507.68-783.04-151.85-76.8444.72-547.96-330.68-323.44111.045274.39-35.99-66.77
Surprise-------------------------------------------
Timing--------------------------------Pre-market----------

Key Statistics & Ratios

Market Cap23.32B
Enterprise Value78.31B
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.03
Price / Book0.19
Revenue (TTM)22.73B
Gross Profit (TTM)3.33B
EBITDA-4.38B
Profit Margin119.33%
Operating Margin-15.21%
Return on Equity-83.96%
Return on Assets-4.06%
Shares Outstanding5.58M
Shares Float3.75M
Beta-0.19
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Nov 11, 20221:20
  • Aug 11, 20221:5
  • Nov 28, 2016959692:319897